Home › All Companies › CAPR › Annual Report

CAPRICOR THERAPEUTICS, INC. (CAPR) — Annual Report

AI-Powered SEC Filing Analysis

← All CAPR filings
Latest Annual Report Filed: 2026-03-17

Key Insights

  • The company executed a September 2025 At-The-Market (ATM) stock offering program, raising additional capital to fund operations and research and development activities.
  • The company completed a December 2025 underwritten public offering, further strengthening its balance sheet and financial position.
  • The company has established a commercialization and distribution agreement with Nippon Shinyaku Co., Ltd. for the United States and Japan, which provides potential revenue streams and expanded market access.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-17. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for CAPRICOR THERAPEUTICS, INC.

Current Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.